Dr Le on the Investigation of Osimertinib and Chemotherapy in Metastatic Lung Cancer
Xiuning Le, MD, PhD, discusses ongoing and future investigations with osimertinib and chemotherapy in patients with metastatic lung cancer.
Stay updated with breaking news from Xiuning Le. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xiuning Le, MD, PhD, discusses ongoing and future investigations with osimertinib and chemotherapy in patients with metastatic lung cancer.
/PRNewswire/ -- The Lung Cancer Research Foundation® (LCRF) is pleased to announce the awardees of its 2022 Scientific Grant Program. This years' grant cycle...
/PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) and MET Crusaders are pleased to announce funding of three grants focused on MET alteration-specific...
BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced data from a poster presentation titled: High Activity of Poziotinib in G778_P780dup HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer (N...
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced data from a poster presentation titled: High Activity of